These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27307599)

  • 1. BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.
    Bansal N; Bartucci M; Yusuff S; Davis S; Flaherty K; Huselid E; Patrizii M; Jones D; Cao L; Sydorenko N; Moon YC; Zhong H; Medina DJ; Kerrigan J; Stein MN; Kim IY; Davis TW; DiPaola RS; Bertino JR; Sabaawy HE
    Clin Cancer Res; 2016 Dec; 22(24):6176-6191. PubMed ID: 27307599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells.
    Xie J; Mølck C; Paquet-Fifield S; Butler L; ; Sloan E; Ventura S; Hollande F
    Oncotarget; 2016 Jul; 7(28):44492-44504. PubMed ID: 27283984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion.
    Bansal N; Davis S; Tereshchenko I; Budak-Alpdogan T; Zhong H; Stein MN; Kim IY; Dipaola RS; Bertino JR; Sabaawy HE
    Prostate; 2014 Feb; 74(2):187-200. PubMed ID: 24154958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma.
    Dubrovska A; Elliott J; Salamone RJ; Kim S; Aimone LJ; Walker JR; Watson J; Sauveur-Michel M; Garcia-Echeverria C; Cho CY; Reddy VA; Schultz PG
    Clin Cancer Res; 2010 Dec; 16(23):5692-702. PubMed ID: 21138868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression.
    Su W; Han HH; Wang Y; Zhang B; Zhou B; Cheng Y; Rumandla A; Gurrapu S; Chakraborty G; Su J; Yang G; Liang X; Wang G; Rosen N; Scher HI; Ouerfelli O; Giancotti FG
    Cancer Cell; 2019 Aug; 36(2):139-155.e10. PubMed ID: 31327655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective AKT Inhibition by MK-2206 Represses Colorectal Cancer-Initiating Stem Cells.
    Malkomes P; Lunger I; Luetticke A; Oppermann E; Haetscher N; Serve H; Holzer K; Bechstein WO; Rieger MA
    Ann Surg Oncol; 2016 Sep; 23(9):2849-57. PubMed ID: 27059026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate.
    Cui J; Hollmén M; Li L; Chen Y; Proulx ST; Reker D; Schneider G; Detmar M
    Oncotarget; 2017 Jan; 8(1):1007-1022. PubMed ID: 27894093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer.
    Crea F; Hurt EM; Mathews LA; Cabarcas SM; Sun L; Marquez VE; Danesi R; Farrar WL
    Mol Cancer; 2011 Apr; 10():40. PubMed ID: 21501485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells.
    Shimada K; Anai S; Fujii T; Tanaka N; Fujimoto K; Konishi N
    J Pathol; 2013 Dec; 231(4):495-504. PubMed ID: 24549646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB.
    Civenni G; Longoni N; Costales P; Dallavalle C; García Inclán C; Albino D; Nuñez LE; Morís F; Carbone GM; Catapano CV
    Mol Cancer Ther; 2016 May; 15(5):806-18. PubMed ID: 26826115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI-1 Promotes Self-Renewal of Radio- and Temozolomide (TMZ)-Resistant Breast Cancer Cells.
    Yan Y; Wang Y; Zhao P; Ma W; Hu Z; Zhang K
    Reprod Sci; 2017 Dec; 24(12):1620-1629. PubMed ID: 28270035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer.
    Han Z; Wang X; Ma L; Chen L; Xiao M; Huang L; Cao Y; Bai J; Ma D; Zhou J; Hong Z
    Oncotarget; 2014 Sep; 5(18):8416-28. PubMed ID: 25261365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel hedgehog inhibitor iG2 suppresses tumorigenesis by impairing self-renewal in human bladder cancer.
    Zhu L; Ni C; Dong B; Zhang Y; Shi Y; Niu H; Li C
    Cancer Med; 2016 Sep; 5(9):2579-86. PubMed ID: 27465044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
    Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
    Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by Increasing
    De S; Lindner DJ; Coleman CJ; Wildey G; Dowlati A; Stark GR
    Cancer Res; 2018 May; 78(9):2396-2406. PubMed ID: 29440145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PMP22 Regulates Self-Renewal and Chemoresistance of Gastric Cancer Cells.
    Cai W; Chen G; Luo Q; Liu J; Guo X; Zhang T; Ma F; Yuan L; Li B; Cai J
    Mol Cancer Ther; 2017 Jun; 16(6):1187-1198. PubMed ID: 28336807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
    Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
    Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
    Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
    Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.